Tourette Syndrome and cannabis in Florida
The state currently does not list this condition as qualifying, and the program does not provide open-ended physician discretion to add conditions. Verify with the state regulator, because programs change.
- ✗ No
- LEGAL
- 2.5 oz smokable per 35-…
- POSSESSION
- $75/yr
- STATE FEE
- 7–14 d
- TIMELINE
Florida statute and program
The Florida Medical Marijuana Use Registry is the operating authority for Florida patient certification. The authoritative legal text is: Florida Statute 381.986: Medical use of marijuana. The program portal is at Florida Medical Marijuana Use Registry.
What the evidence says about cannabis and Tourette Syndrome
Tourette syndrome (TS) is a neurodevelopmental disorder characterized by multiple motor tics and one or more vocal tics, with onset typically in childhood. Tic severity varies widely; many patients experience meaningful improvement by adulthood, but a significant minority continue to have functionally disabling tics that respond poorly to first-line behavioral and pharmacologic therapies.
For the full evidence base, including the NASEM tier, randomized trial summaries, and symptom-domain breakdown, read the mmjnow Tourette Syndrome page.
How to qualify in Florida
The Florida Medical Marijuana Use Registry requires the following registration steps for a Tourette Syndrome patient (or any qualifying diagnosis):
- See an OMMU-registered qualified physician. A Florida-licensed MD or DO who has completed the Office of Medical Marijuana Use (OMMU) qualified-physician training and registered with OMMU may evaluate the patient under §381.986. The physician must establish residency in Florida for the patient (Florida driver license or state ID, plus utility bill or comparable documentation for seasonal residents) and must certify one of the ten enumerated conditions or a "comparable class" diagnosis.
- Physician submits certification to the OMMU registry. The qualified physician enters the patient certification into the OMMU Medical Marijuana Use Registry electronically. Once entered, the registry generates an application number that the patient uses for the next step. Patients may not self-register before physician entry.
- Complete the patient application and pay the $75 state fee. The patient logs into the OMMU registry with the application number, uploads a passport-style photograph and Florida driver license or state ID, and pays the $75 annual state ID card fee. Caregivers are registered through the same registry for the same fee and must pass a Level 2 background check.
- Receive the OMMU ID card and purchase from an MMTC. Florida medical marijuana use cards arrive by mail within roughly 10 business days of complete application. Patients may purchase up to 2.5 ounces of smokable cannabis per 35-day supply window and a 70-day supply of non-smokable forms from any of Florida’s licensed Medical Marijuana Treatment Centers (MMTCs). Cards renew annually with a new physician visit and a new $75 fee. Florida does not honor out-of-state medical cards; seasonal residents apply through the same OMMU process.
- State registration fee
- $75
- Physician visit (typical)
- $150–$300
- Certification to card
- 7–14 days
- Out-of-state patients
- Not eligible
- Minors
- Eligible with caregiver
For full Florida registration steps, fees, and reciprocity rules, see the Florida cannabis-laws page.
ICD-10 code
A certifying physician documenting Tourette Syndrome for the Florida medical cannabis program will typically record ICD-10 F95.2 or SNOMED-CT 5158005 in the patient's record. The state registry does not itself collect ICD-10 codes in most programs, but the physician's chart is the audit trail if the certification is later reviewed.
Frequently asked questions
Does Florida list Tourette Syndrome as a qualifying condition for medical cannabis?
No. Florida's qualifying-condition list does not currently include Tourette Syndrome, and the state's program does not give physicians open-ended discretion to add conditions outside the list. Patients with Tourette Syndrome in Florida have limited in-state pathways under the medical program as written. Options to verify and pursue include: petitioning the state regulator to add the condition (where the statute permits public petitions); consulting a physician about whether a co-occurring listed condition could support certification; or reviewing whether the state's program is undergoing legislative expansion. Florida program rules change, so verify the current list with the regulator before drawing a final conclusion.
How do I get a Florida medical marijuana card for Tourette Syndrome?
Because Florida does not currently list Tourette Syndrome as a qualifying condition, a card for Tourette Syndrome alone may not be obtainable in-state under the program rules as written. Step one is finding a physician licensed in Florida who is registered with Florida Medical Marijuana Use Registry and willing to evaluate Tourette Syndrome cases. Step two is collecting your records (diagnosis documentation, treatment history, and the ICD-10 code your physician will use) and bringing them to the certification visit. Step three is the physician's certification through the state registry, followed by the patient registration application, state fee, and waiting period before the card is issued. Florida does not honor out-of-state cards, so the certification process has to originate inside the state. The state minimum patient age is 18; minors generally require a parent or legal guardian to act as caregiver. The authoritative source for the current process is the Florida Medical Marijuana Use Registry site at https://knowthefactsmmj.com/; the state updates fees, forms, and physician registration rules periodically.
What does the evidence say about cannabis for Tourette Syndrome?
For Tourette Syndrome, evidence is described as limited (a small number of supportive studies, often underpowered or focused on narrow symptom domains). The mmjnow condition page for Tourette Syndrome lays out the current evidence base, including the citations underlying that evidence tier — typically the National Academies of Sciences, Engineering, and Medicine consensus reports, federal agency guidance, and peer-reviewed reviews. Evidence quality is independent of state law: a state can list a condition for which evidence is limited, and a state can decline to list a condition for which evidence is strong. Patients deciding whether to pursue medical cannabis for Tourette Syndrome should review the underlying evidence (linked on the condition page) and discuss expected benefit, dosing, and risk with a clinician familiar with both Tourette Syndrome and cannabinoid pharmacology. Cannabis is not a substitute for evidence-based first-line treatments for Tourette Syndrome; the evidence position above describes whether trial data supports its use, not whether it should replace standard care.
Sources
- Florida Statute 381.986: Medical use of marijuanaaccessed May 15, 2026
- Florida Office of Medical Marijuana Use (OMMU)accessed May 15, 2026
- NORML: Florida Laws & Penaltiesaccessed May 15, 2026
- Marijuana Policy Project: Floridaaccessed May 15, 2026
- Florida Statute §893.13: Prohibited acts; penalties (controlled substances)accessed May 17, 2026
- Florida Statute §322.055: Revocation/suspension of driver license for drug convictionsaccessed May 17, 2026
- NORML: Florida — Local Decriminalization Ordinancesaccessed May 17, 2026
- Miami-Dade County Code of Ordinances (Municode) — civil-citation ordinance 15-138 (2015)accessed May 17, 2026
- City of Tampa Code of Ordinances (Municode) — ordinance 2016-46accessed May 17, 2026
- City of Orlando Code of Ordinances (Municode) — ordinance 2016-29accessed May 17, 2026
- NASEM: The Health Effects of Cannabis and Cannabinoids (2017)accessed May 15, 2026
“Limited evidence that THC capsules are effective for the treatment of Tourette syndrome.”
- Tourette Association of Americaaccessed May 15, 2026